• AAPL 191.875
  • TSLA 240.64
  • AMZN 144.38
  • BTC-USD 41842.2695
  • ETH-USD 2217.1794
  • EURUSD 1.0747
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. US /
  3. PSYGF.US

Psyence Group Inc (PSYGF PINK) stock market data APIs

$0.0671 0(0%) as of December 8, 2023

Psyence Group Inc Financial Data Overview

0.0671
0.0671
-
0.0671
0.0671
0.011-0.22
9 219 K
137 M
5 541
-0.0028
0
0.364
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PSYGF',
Type: 'Common Stock',
Name: 'Psyence Group Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG0125C1DZ4',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'March',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - General',
GicSector: NULL,
GicGroup: NULL,
GicIndustry: NULL,
GicSubIndustry: NULL,
HomeCategory: NULL,
IsDelisted: false,
}

Psyence Group Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 5 541
  • EBITDA -6 423 402
  • Earnings Per Share -0.04
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $49.99 See full price
Get sample
of Fundamental API Data

Get Psyence Group Inc Earnings via APIs

  • Latest Release 2023-09-30
  • EPS/Forecast NaN

Get Psyence Group Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Psyence Group Inc latest news via APIs

Psyence Group Announces Resignation of Board Member

TORONTO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE:PSYG) (“Psyence” or the “Company”), a clinical-stage life science biotechnology company pioneering the use of nature-derive...
  • CANADIAN STOCK EXCHANGE:PSYG.CN
  • DIRECTORS AND OFFICERS
  • PSYENCE GROUP INC

Psyence Group Announces SEC Effectiveness of F-4 for Proposed Business Combination Between Subsidiary and Nasdaq Listed Newcourt Acquisition Corp

TORONTO, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE:PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wel...
  • BUSINESS CONTRACTS
  • CANADIAN STOCK EXCHANGE:PSYG.CN
  • MERGERS AND ACQUISITIONS
  • PSYENCE GROUP INC
Still have any questions?

Or need any other data for equities, funds or ETFs? Send us an email.

support@eodhistoricaldata.com